Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ: ARCT · Real-Time Price · USD

6.68

-0.32 (-4.57%)

At close: Mar 13, 2026, 4:00 PM EDT

6.82

+0.14 (2.10%)

After-hours: Mar 13, 2026, 7:26 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Discovery, Development and Commercialization of Messenger RNA Medicines	82.03M	152.31M	166.80M	206.00M	12.36M
Discovery, Development and Commercialization of Messenger RNA Medicines Growth	-46.14%	-8.69%	-19.03%	1566.79%	29.56%
Total	82.03M	152.31M	166.80M	206.00M	12.36M
Total Growth	-46.14%	-8.69%	-19.03%	1566.79%	29.56%

Source: S&P Global Market Intelligence.